Zobrazeno 1 - 10
of 200
pro vyhledávání: '"Jitmuang A"'
Publikováno v:
Infection and Drug Resistance, Vol Volume 14, Pp 3873-3881 (2021)
Parita Dankul,1 Khemajira Karaketklang,1 Anupop Jitmuang2 1Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; 2Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of
Externí odkaz:
https://doaj.org/article/903d4e0ffa314fbab0e5bc2de6aa3198
Publikováno v:
Infection and Drug Resistance, Vol Volume 13, Pp 1559-1566 (2020)
Worachart Insuwanno,1 Pattarachai Kiratisin,2 Anupop Jitmuang3 1Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; 2Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University
Externí odkaz:
https://doaj.org/article/97bc7637f72146ac85dea2676ba2fd8c
Autor:
Jitmuang, Anupop1 (AUTHOR), Lertlaksameewilai, Panuwat2 (AUTHOR), Poorichitiporn, Arnon3 (AUTHOR), Horthongkham, Navin4 (AUTHOR), Chayakulkeeree, Methee1 (AUTHOR) methee.cha@mahidol.ac.th
Publikováno v:
Open Forum Infectious Diseases. Jul2024, Vol. 11 Issue 7, p1-10. 10p.
The burden of carbapenem-resistant Enterobacterales infection in a large Thai tertiary care hospital
Autor:
Watcharaphon Tangsawad, Chayanis Kositamongkol, Piriyaporn Chongtrakool, Pochamana Phisalprapa, Anupop Jitmuang
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Carbapenem-resistant Enterobacterales (CRE) are resistant to several other classes of antimicrobials, reducing treatment options and increasing mortality. We studied the clinical characteristics and burden of hospitalized adult patients w
Externí odkaz:
https://doaj.org/article/2132aa6d6e6443368398b53cef64c9b6
Autor:
Pannathat Soontrapa, Anupop Jitmuang, Pichet Ruenchit, Supathra Tiewcharoen, Patsharaporn T. Sarasombath, Chatchawan Rattanabannakit
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
Primary amebic meningoencephalitis (PAM) is a rare and fatal central nervous system infection caused by Naegleria fowleri, a free-living amoeba found in the environment. To date, eight pathogenic N. fowleri genotypes have been reported worldwide. We
Externí odkaz:
https://doaj.org/article/819169f0238e48ca90e34318e277df78
Autor:
Saifon Chawanpaiboon, Nalat Sompagdee, Sriwipa Kaewsrinual, Kanitta Srikrisanapol, Anupop Jitmuang, Piyawat Matrakool, Jirawadee Yodying, Taksaporn Sakrattana-anant, Piyawadee Wangmanao, Pornphet Songsirithat, Runchida Saengsiriwudh, Kongkaew Ngowsirigool, Jirapon Jesrichai, Techin Wasinsangworn
Publikováno v:
American Journal of Case Reports; 5/26/2024, Vol. 25, p1-8, 8p
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-7 (2018)
Abstract Background Cryptococcus gattii is known to be an etiologic agent of human cryptococcosis, particularly in immunocompetent persons. C. gattii infection usually involves the central nervous system, the respiratory tract, or may be disseminated
Externí odkaz:
https://doaj.org/article/a6e93298098b4728952d1852f27c92f6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nattawan Palavutitotai, Anupop Jitmuang, Sasima Tongsai, Pattarachai Kiratisin, Nasikarn Angkasekwinai
Publikováno v:
PLoS ONE, Vol 13, Iss 2, p e0193431 (2018)
The incidence of nosocomial infections from extensively drug-resistant Pseudomonas aeruginosa (XDR-PA) has been increasing worldwide. We investigated the prevalence and factors associated with XDR-PA infections, including the factors that predict mor
Externí odkaz:
https://doaj.org/article/faa9ee8e760d421a8aaf308026fe5f98
Autor:
Anthony C. Gordon, Anupop Jitmuang, Timothy B. Hallett, Graham S Cooke, Adhiratha Boonyasiri, Ester Cerdeira Sabino, Hayley A Thompson, Pratthana Srisangthong, Maria Eugenia Grillet, Zarir F Udwadia, Shevanthi Nayagam, Lantharita Charoenpong, Diana M. Gibb, Andrew N. Phillips, Sorawat Sangkaew, Djayanti Sari, Carlos Alvarez-Moreno, Gustavo Lopardo, Azra C. Ghani, Patrick G T Walker, Panuwat Promsin, Bimandra A Djaafara, Ng’ang’a Irene Hannah Njeri, Anna S. Levin, Zulma M. Cucunubá, Cássia Fernanda Estofolete, Oliver J Watson, Nuno R. Faria, Maurício Lacerda Nogueira, Charles Whittaker, Methee Chayakulkeeree, Raph L. Hamers, Arran Hamlet, Nasikarn Angkasekwinai, Luis Carlos Triana, Teresia Njoki Kimani, Thundon Ngamprasertchai, Mauricio W. Perroud, Vera Irawany, Julio Croda, Silvia Figueiredo Costa, Rujipas Sirijatuphat, David A Forero-Peña, Margarita Lampo, Ambar Qavi, Nukool Keurueangkul, Alison Rodger, Peter Winskill, Rima Mustafa, Esteban Ortiz-Prado, Duncan Chanda, Sandra Valderrama-Beltrán, Andrei C. Sposito
Publikováno v:
Clinical infectious diseases, 75(1), E224-E233. Oxford University Press
Background The public health impact of the coronavirus disease 2019 (COVID-19) pandemic has motivated a rapid search for potential therapeutics, with some key successes. However, the potential impact of different treatments, and consequently research
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7140c4c5339efe11e8fb279d2798fa5
https://doi.org/10.1093/cid/ciab837
https://doi.org/10.1093/cid/ciab837